Both TRIM5α and TRIMCyp have only weak antiviral activity in canine D17 cells
2007

Weak Antiviral Activity of TRIM5α and TRIMCyp in Canine Cells

publication Evidence: moderate

Author Information

Author(s): Bérubé Julie, Bouchard Amélie, Berthoux Lionel

Primary Institution: Laboratory of Retrovirology, GRBCM, University of Québec, Trois-Rivières, QC, Canada

Hypothesis

Canine D17 cells provide a poor environment for the inhibition of retroviral replication by TRIM5α and TRIMCyp.

Conclusion

D17 cells are not effective at restricting retroviral replication by TRIM5α and TRIMCyp due to an impaired restriction mechanism.

Supporting Evidence

  • TRIM5α and TRIMCyp showed poor antiviral activity in D17 cells despite normal expression levels.
  • In D17 cells, the restriction of HIV-1 and N-MLV was significantly lower compared to other cell types.
  • The study suggests that an unknown factor necessary for TRIM5α and TRIMCyp activity is missing in D17 cells.

Takeaway

The proteins TRIM5α and TRIMCyp, which usually help stop viruses, don't work well in a certain type of dog cells.

Methodology

The study involved transducing various TRIM5α orthologues and TRIMCyp into canine D17 cells and assessing their antiviral activity against HIV-1 and N-MLV.

Limitations

The study does not identify the specific cellular factors that impair TRIM5α and TRIMCyp activity in D17 cells.

Digital Object Identifier (DOI)

10.1186/1742-4690-4-68

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication